Intrinsic Value of S&P & Nasdaq Contact Us

Indaptus Therapeutics, Inc. INDP NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
57/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — INDP

Indaptus Therapeutics, Inc. (INDP) has a market capitalization of $4.08M and trades at $2.33. The 52-week range is 1.52-19.908.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.1, Earnings Per Share (EPS) of $-21.58.

The stock has a beta of 0.99, operates in the Healthcare sector.

Trading Data
Current Price$2.33
52-Week Range1.52-19.908
Volume249.85K
Avg Volume (30D)51.3K
Market Cap$4.08M
Beta (1Y)0.99
Company
IPO Date2015-08-04
Employees7
CEODavid Elliot Lazar
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS45339J2042
CUSIP45339J204
Income (Latest Year)
EBITDA$-19.83M
Operating Income$-19.83M
Net Income$-20.85M
EPS$-21.58
EPS Diluted$-21.58
Shares Outstanding$966.12K
Balance Sheet (Latest Year)
Total Assets$9.31M
Current Assets$9.31M
Cash & ST Investments$8.51M
Total Liabilities$6.16M
Net Debt$-8.51M
Total Equity$3.15M
Valuation Ratios
P/E Ratio-0.1
P/B Ratio1.29
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message